TNF and rheumatoid arthritis: Recently, an attempt to assess the differential properties of different substances used in the treatment of RA was performed at whole blood transcriptome level of human patients [11], producing different gene signatures that reflected the mechanistic differences of the tested biologics (an anti-TNF, an anti IL6-R and an inhibitor of T-cell maturation).